NeoGenomics (NEO) Insider Lynn Tetrault Sells $59K of Stock

On June 15, 2026, Lynn Tetrault sold 5,307 shares of NEO at an average price of $11.10 per share. This planned transaction was valued at $58,907.70. Tetrault's sale is part of a broader trend of activity among NEO's insiders and institutional investors.

Other Institutional Activity in NEO

Several major funds have also been active in NEO. BlackRock, Inc. increased its holdings by 496,153 shares, bringing its total to 19,957,502 shares valued at approximately $148.08 million. In contrast, First Light Asset Management, LLC reduced its position by 305,085 shares, now holding 9,729,978 shares worth about $72.20 million. Greenhouse Funds LLLP added 456,257 shares, ending with 9,100,103 shares valued at $67.52 million. Meanwhile, Vanguard Portfolio Management LLC and First Trust Advisors LP both initiated positions, each acquiring over 5 million shares.

NeoGenomics, Inc. Stock Down 47.3%

Shares of NEO traded near $10.49 recently. The company's stock has seen significant activity, with institutional investors making notable adjustments to their holdings. While specific financial metrics like market cap and P/E ratio aren't available, the stock's recent trading activity indicates a dynamic market environment.

Insider Buying and Selling at NeoGenomics, Inc.

In addition to Lynn Tetrault's recent sale, other insiders have been active. On June 9, 2026, Tetrault sold another 5,307 shares at $11.29 each. Earlier, on June 1, 2026, Stephen Kanovsky sold 23,077 shares, while John Kenny, Marjorie Green, and Felicia Williams each bought shares, with Green acquiring 22,964 shares.

Analysts Set New Price Targets

Analysts have been optimistic about NEO's prospects. On April 29, 2026, Benchmark upgraded NEO to a buy rating with an $11.00 price target. TD Cowen maintained its buy rating, setting a target of $14.00, while Leerink Partners upgraded the stock with a $25.00 target. The consensus among analysts remains positive, with a general buy recommendation and varied price targets.

Bottom Line

Lynn Tetrault's planned sale of NEO shares is part of a broader pattern of insider and institutional activity. Investors often track these moves for insights into market sentiment. While 13F filings and insider transactions provide valuable historical data, they may not reflect current positions. Analysts remain bullish on NEO, with several firms maintaining or raising their price targets, suggesting continued interest in the stock.